Literature DB >> 20689084

MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage.

Eric E Smith1, Kaveer R N Nandigam, Yu-Wei Chen, Jed Jeng, David Salat, Amy Halpin, Matthew Frosch, Lauren Wendell, Louis Fazen, Jonathan Rosand, Anand Viswanathan, Steven M Greenberg.   

Abstract

BACKGROUND AND
PURPOSE: MRI evidence of small vessel disease is common in intracerebral hemorrhage (ICH). We hypothesized that ICH caused by cerebral amyloid angiopathy (CAA) or hypertensive vasculopathy would have different distributions of MRI T2 white matter hyperintensity (WMH) and microbleeds.
METHODS: Data were analyzed from 133 consecutive patients with primary supratentorial ICH and adequate MRI sequences. CAA was diagnosed using the Boston criteria. WMH segmentation was performed using a validated semiautomated method. WMH and microbleeds were compared according to site of symptomatic hematoma origin (lobar versus deep) or by pattern of hemorrhages, including both hematomas and microbleeds, on MRI gradient recalled echo sequence (grouped as lobar only-probable CAA, lobar only-possible CAA, deep hemispheric only, or mixed lobar and deep hemorrhages).
RESULTS: Patients with lobar and deep hemispheric hematoma had similar median normalized WMH volumes (19.5 cm versus 19.9 cm(3), P=0.74) and prevalence of >or=1 microbleed (54% versus 52%, P=0.99). The supratentorial WMH distribution was similar according to hemorrhage location category; however, the prevalence of brain stem T2 hyperintensity was lower in lobar hematoma versus deep hematoma (54% versus 70%, P=0.004). Mixed ICH was common (23%). Patients with mixed ICH had large normalized WMH volumes and a posterior distribution of cortical hemorrhages similar to that seen in CAA.
CONCLUSIONS: WMH distribution is largely similar between CAA-related and non-CAA-related ICH. Mixed lobar and deep hemorrhages are seen on MRI gradient recalled echo sequence in up to one fourth of patients; in these patients, both hypertension and CAA may be contributing to the burden of WMH.

Entities:  

Mesh:

Year:  2010        PMID: 20689084      PMCID: PMC4084787          DOI: 10.1161/STROKEAHA.110.579078

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  23 in total

1.  Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy.

Authors:  Jonathan Rosand; Alona Muzikansky; Ashok Kumar; Jonathan J Wisco; Eric E Smith; Rebecca A Betensky; Steven M Greenberg
Journal:  Ann Neurol       Date:  2005-09       Impact factor: 10.422

2.  Role of cerebral amyloid angiopathy in intracerebral hemorrhage in hypertensive patients.

Authors:  M A Ritter; D W Droste; K Hegedüs; R Szepesi; D G Nabavi; L Csiba; E B Ringelstein
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

3.  Cerebral microbleeds in patients with hypertensive stroke. Topographical distribution in the supratentorial area.

Authors:  Seung-Hoon Lee; Seon-Joo Kwon; Ki Soon Kim; Byung-Woo Yoon; Jae-Kyu Roh
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

4.  White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage.

Authors:  E E Smith; M E Gurol; J A Eng; C R Engel; T N Nguyen; J Rosand; S M Greenberg
Journal:  Neurology       Date:  2004-11-09       Impact factor: 9.910

5.  Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.

Authors:  M E Gurol; M C Irizarry; E E Smith; S Raju; R Diaz-Arrastia; T Bottiglieri; J Rosand; J H Growdon; S M Greenberg
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

6.  Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

Authors:  Ihab Hajjar; Theodore A Kotchen
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

7.  Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly.

Authors:  Y Itoh; M Yamada; M Hayakawa; E Otomo; T Miyatake
Journal:  J Neurol Sci       Date:  1993-06       Impact factor: 3.181

8.  Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes.

Authors:  H V Vinters; J J Gilbert
Journal:  Stroke       Date:  1983 Nov-Dec       Impact factor: 7.914

9.  Grading white matter lesions on CT and MRI: a simple scale.

Authors:  J C van Swieten; A Hijdra; P J Koudstaal; J van Gijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-12       Impact factor: 10.154

10.  Cerebral microbleeds are regionally associated with intracerebral hemorrhage.

Authors:  S H Lee; H J Bae; S J Kwon; H Kim; Y H Kim; B W Yoon; J K Roh
Journal:  Neurology       Date:  2004-01-13       Impact factor: 9.910

View more
  30 in total

Review 1.  Leukoaraiosis and stroke.

Authors:  Eric E Smith
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

Review 2.  Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies?

Authors:  Kellen E Haley; Steven M Greenberg; M Edip Gurol
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

3.  Renal dysfunction is associated with deep cerebral microbleeds but not white matter hyperintensities in patients with acute intracerebral hemorrhage.

Authors:  Mona Laible; Solveig Horstmann; Markus Möhlenbruch; Christian Wegele; Timolaos Rizos; Svenja Schüler; Markus Zorn; Roland Veltkamp
Journal:  J Neurol       Date:  2015-07-15       Impact factor: 4.849

4.  Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage.

Authors:  Sergi Martinez-Ramirez; Jose-Rafael Romero; Ashkan Shoamanesh; Ann C McKee; Ellis Van Etten; Octavio Pontes-Neto; Eric A Macklin; Alison Ayres; Eitan Auriel; Jayandra J Himali; Alexa S Beiser; Charles DeCarli; Thor D Stein; Victor E Alvarez; Matthew P Frosch; Jonathan Rosand; Steven M Greenberg; M Edip Gurol; Sudha Seshadri; Anand Viswanathan
Journal:  Alzheimers Dement       Date:  2015-06-13       Impact factor: 21.566

5.  Posterior white matter disease distribution as a predictor of amyloid angiopathy.

Authors:  Sekh Thanprasertsuk; Sergi Martinez-Ramirez; Octavio Marques Pontes-Neto; Jun Ni; Alison Ayres; Anne Reed; Kyleen Swords; M Edip Gurol; Steven M Greenberg; Anand Viswanathan
Journal:  Neurology       Date:  2014-07-25       Impact factor: 9.910

6.  Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging.

Authors:  Yi-Cheng Zhu; Hugues Chabriat; Ophélia Godin; Carole Dufouil; Jonathan Rosand; Steven M Greenberg; Eric E Smith; Christophe Tzourio; Anand Viswanathan
Journal:  J Neurol       Date:  2011-08-30       Impact factor: 4.849

Review 7.  Cerebral amyloid angiopathy in the elderly.

Authors:  Anand Viswanathan; Steven M Greenberg
Journal:  Ann Neurol       Date:  2011-12       Impact factor: 10.422

Review 8.  APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis.

Authors:  Sabrina Schilling; Anita L DeStefano; Perminder S Sachdev; Seung Hoan Choi; Karen A Mather; Charles D DeCarli; Wei Wen; Peter Høgh; Naftali Raz; Rhoda Au; Alexa Beiser; Philip A Wolf; José Rafael Romero; Yi-Cheng Zhu; Kathryn L Lunetta; Lindsay Farrer; Carole Dufouil; Lewis H Kuller; Bernard Mazoyer; Sudha Seshadri; Christophe Tzourio; Stéphanie Debette
Journal:  Neurology       Date:  2013-07-16       Impact factor: 9.910

9.  White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy.

Authors:  Andreas Charidimou; Gregoire Boulouis; Kellen Haley; Eitan Auriel; Ellis S van Etten; Panagiotis Fotiadis; Yael Reijmer; Alison Ayres; Anastasia Vashkevich; Zora Y Dipucchio; Kristin M Schwab; Sergi Martinez-Ramirez; Jonathan Rosand; Anand Viswanathan; Steven M Greenberg; M Edip Gurol
Journal:  Neurology       Date:  2016-01-08       Impact factor: 9.910

10.  Cerebral microbleeds: a guide to detection and clinical relevance in different disease settings.

Authors:  Andreas Charidimou; Anant Krishnan; David J Werring; H Rolf Jäger
Journal:  Neuroradiology       Date:  2013-05-25       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.